490646815	490646815	CD	B-NP	O
|	|	NNP	I-NP	O
NEH	NEH	NNP	I-NP	O
|	|	VBD	B-VP	O
31530471	31530471	CD	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
6016851	6016851	CD	B-NP	O
|	|	CC	I-NP	O
2/7/2007	2/7/2007	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
Partial	Partial	JJ	I-NP	O
small	small	JJ	I-NP	O
bowel	bowel	NN	I-NP	O
obstruction	obstruction	NN	I-NP	O
,	,	,	O	O
pneumonia	pneumonia	NN	B-NP	O
,	,	,	O	O
CHF	CHF	NN	B-NP	B-protein
|	|	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/7/2007	10/7/2007	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
9/23/2007	9/23/2007	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NN	I-NP	O
******	******	SYM	B-VP	O
MEGRAW	MEGRAW	NN	B-NP	O
,	,	,	O	O
JAMIE	JAMIE	NN	B-NP	O
B	B	NN	I-NP	O
225-82-41-7	225-82-41-7	CD	I-NP	O
Rock	Rock	NNP	I-NP	O
Simin	Simin	NNP	I-NP	O
Burg	Burg	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
8/19/07	8/19/07	CD	B-NP	O
AT	AT	NN	I-NP	O
02	02	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
NO	NO	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
see	see	VBP	B-VP	O
an	an	DT	B-NP	O
addendum	addendum	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Attending	Attend	VBG	B-VP	O
:	:	:	O	O
ROBICHARD	ROBICHARD	NNP	B-NP	O
,	,	,	O	O
DOYLE	DOYLE	NNP	B-NP	O
J	J	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
ADDENDUM	ADDENDUM	NN	B-NP	O
1	1	CD	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Addended	Addended	NNP	I-NP	O
Gaton	Gaton	NNP	I-NP	O
,	,	,	O	O
Darrell	Darrell	NNP	B-NP	O
B.	B.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
GO640	GO640	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
on	on	IN	B-PP	O
1/15/07	1/15/07	CD	B-NP	O
@	@	NN	I-NP	O
02	02	CD	I-NP	O
:	:	:	O	O
54	54	CD	B-NP	O
PM	PM	NN	I-NP	O
CODE	CODE	NN	I-NP	O
STATUS	STATUS	NNS	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
services	service	NNS	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

AMLODIPINE	AMLODIPINE	NN	B-NP	B-protein
5	5	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
QAM	QAM	NN	I-NP	I-protein
2	2	CD	I-NP	I-protein
.	.	.	O	O

AMLODIPINE	AMLODIPINE	NN	B-NP	O
2.5	2.5	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QPM	QPM	NN	I-NP	O
3	3	CD	I-NP	O
.	.	.	O	O

CALCIUM	CALCIUM	NN	B-NP	B-protein
CARBONATE	CARBONATE	NN	I-NP	I-protein
1500	1500	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
-LRB-	-LRB-	HYPH	B-NP	I-protein
600	600	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
ELEM	ELEM	NN	I-NP	I-protein
CA	CA	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
/	/	SYM	B-VP	O
VIT	VIT	NN	B-NP	B-protein
D	D	NN	I-NP	I-protein
200	200	CD	B-NP	I-protein
IU	IU	NN	I-NP	I-protein
1	1	CD	B-NP	I-protein
TAB	TAB	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
BID	BID	NN	I-NP	I-protein
4	4	CD	I-NP	I-protein
.	.	.	O	O

DOCUSATE	DOCUSATE	JJ	B-NP	O
SODIUM	SODIUM	NN	I-NP	O
100	100	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
BID	BID	NN	I-NP	B-protein
5	5	CD	I-NP	I-protein
.	.	.	O	O

EPOETIN	EPOETIN	NN	B-NP	B-protein
ALFA	ALFA	NN	I-NP	I-protein
5000	5000	CD	I-NP	I-protein
UNITS	UNITS	NNP	I-NP	I-protein
SC	SC	NNP	I-NP	I-protein
QWEEK	QWEEK	NNP	I-NP	I-protein
6	6	CD	I-NP	I-protein
.	.	.	O	O

ESOMEPRAZOLE	ESOMEPRAZOLE	RB	B-NP	O
40	40	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
7	7	CD	I-NP	O
.	.	.	O	O

FERROUS	FERROUS	DT	B-NP	O
SULFATE	SULFATE	JJ	I-NP	O
325	325	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
BID	BID	NN	I-NP	B-protein
8	8	CD	I-NP	I-protein
.	.	.	O	O

FUROSEMIDE	FUROSEMIDE	NN	B-NP	B-protein
80	80	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
BID	BID	NN	I-NP	I-protein
9	9	CD	I-NP	I-protein
.	.	.	O	O

INSULIN	INSULIN	NNP	B-NP	B-protein
ASPART	ASPART	NNP	I-NP	O
SLIDING	SLIDING	NNP	I-NP	O
SCALE	SCALE	NNP	I-NP	O
SC	SC	NNP	I-NP	O
AC	AC	NNP	I-NP	O
10	10	CD	I-NP	O
.	.	.	O	O

INSULIN	INSULIN	NNP	B-NP	B-protein
ASPART	ASPART	NNP	I-NP	O
4	4	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
WITH	WITH	NNP	I-NP	O
BREAKFAST	BREAKFAST	NNPS	I-NP	B-cell_type
AND	AND	CC	B-NP	O
WITH	WITH	NN	I-NP	B-DNA
LUNCH	LUNCH	NN	I-NP	I-DNA
11	11	CD	I-NP	I-DNA
.	.	.	O	O

INSULIN	INSULIN	NN	B-NP	B-protein
GLARGINE	GLARGINE	NN	I-NP	I-protein
8	8	CD	I-NP	I-protein
UNITS	UNITS	NNP	I-NP	I-protein
SC	SC	NNP	I-NP	O
QD	QD	NNP	I-NP	O
12	12	CD	I-NP	O
.	.	.	O	O

ISOSORBIDE	ISOSORBIDE	NNP	B-NP	O
MONONITRATE	MONONITRATE	NNP	I-NP	O
30	30	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
13	13	CD	I-NP	O
.	.	.	O	O

SEVELAMER	SEVELAMER	NN	B-NP	O
400	400	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QPM	QPM	NN	I-NP	O
14	14	CD	I-NP	O
.	.	.	O	O

VALSARTAN	VALSARTAN	NN	B-NP	B-protein
120	120	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	O
15	15	CD	I-NP	O
.	.	.	O	O

WARFARIN	WARFARIN	NN	B-NP	B-protein
SODIUM	SODIUM	NN	I-NP	I-protein
1	1	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
QPM	QPM	NNP	I-NP	O
MEDICATIONS	MEDICATIONS	NNP	I-NP	O
ON	ON	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
:	:	:	O	O
NORVASC	NORVASC	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
AMLODIPINE	AMLODIPINE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
5	5	CD	I-NP	O
MG	MG	NNP	I-NP	O
QAM	QAM	NNP	I-NP	O
;	;	:	O	O
2.5	2.5	CD	B-NP	O
MG	MG	NN	I-NP	O
QPM	QPM	NN	I-NP	O
PO	PO	NN	I-NP	O
5	5	CD	I-NP	O
MG	MG	NN	I-NP	O
QAM	QAM	NN	I-NP	O
2.5	2.5	CD	I-NP	O
MG	MG	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
CRUSHED	CRUSHED	NNP	B-NP	O
MEDS	MEDS	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	B-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

CALCIUM	CALCIUM	NN	B-NP	O
CARBONATE	CARBONATE	NN	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
500	500	CD	I-NP	O
MG	MG	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
600	600	CD	I-NP	O
MG	MG	NN	I-NP	O
ELEM	ELEM	NN	I-NP	O
CA	CA	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
/	/	SYM	B-VP	O
VIT	VIT	NN	B-NP	O
D	D	NN	I-NP	O
200	200	CD	B-NP	O
IU	IU	NN	I-NP	O
1	1	CD	B-NP	O
TAB	TAB	NN	I-NP	O
PO	PO	NN	I-NP	O
BID	BID	NN	I-NP	O
PROCRIT	PROCRIT	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
NON-ONCOLOGY	NON-ONCOLOGY	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
EPOETIN	EPOETIN	NN	I-NP	O
ALFA	ALFA	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
NON-ONC	NON-ONC	NN	I-NP	O
...	...	:	O	O
-RRB-	-RRB-	NN	B-NP	O
5	5	CD	I-NP	O
,	,	,	O	O
000	000	CD	B-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
QWEEK	QWEEK	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
on	on	IN	B-PP	O
tuesday	tuesday	NNP	B-NP	O
FERROUS	FERROUS	NNP	I-NP	O
SULFATE	SULFATE	NNP	I-NP	O
325	325	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
milk	milk	NN	I-NP	O
and	and	CC	I-NP	O
antacid	antacid	NN	I-NP	O
LASIX	LASIX	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
FUROSEMIDE	FUROSEMIDE	NN	I-NP	B-protein
-RRB-	-RRB-	HYPH	B-NP	I-protein
160	160	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
BID	BID	NN	I-NP	I-protein
HOLD	HOLD	NN	I-NP	I-protein
IF	IF	NN	I-NP	I-protein
:	:	:	O	O
SBP	SBP	NN	B-NP	B-protein
<	<	SYM	O	I-protein
100	100	CD	B-NP	I-protein
INSULIN	INSULIN	NNP	I-NP	I-protein
ASPART	ASPART	NNP	I-NP	O
Sliding	Sliding	NNP	I-NP	O
Scale	Scale	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
-RRB-	-RRB-	NNP	B-NP	O
SC	SC	NNP	I-NP	O
AC+HS	AC+HS	NNP	I-NP	O
Low	Low	NNP	I-NP	O
Scale	Scale	NNP	I-NP	O
Call	Call	NNP	I-NP	O
HO	HO	NN	I-NP	O
if	if	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
60	60	CD	I-NP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
125	125	CD	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
DO	DO	NNP	B-NP	O
NOT	NOT	NNP	I-NP	O
Administer	Administer	NNP	I-NP	O
supplemental	supplemental	JJ	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
insulin	insulin	NN	I-NP	I-protein
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
125-150	125-150	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
0	0	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
151-200	151-200	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
1	1	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
201-250	201-250	CD	B-NP	O
,	,	,	O	O
then	then	RB	O	O
give	give	VB	B-VP	O
2	2	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
251-300	251-300	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
3	3	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
301-350	301-350	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
4	4	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
351-400	351-400	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
5	5	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
Call	Call	VBP	B-VP	O
HO	HO	NN	B-NP	B-protein
if	if	IN	B-SBAR	I-protein
BS	BS	NNP	B-NP	I-protein
is	be	VBZ	B-VP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
350	350	CD	B-NP	O
If	If	IN	B-SBAR	O
ordered	order	VBN	B-NP	O
QAC	QAC	NN	I-NP	O
administer	administer	NN	I-NP	O
at	at	IN	B-PP	O
same	same	JJ	B-NP	O
time	time	NN	I-NP	O
as	as	IN	B-PP	O
,	,	,	O	O
and	and	CC	O	O
in	in	IN	B-PP	O
addition	addition	NN	B-NP	O
to	to	TO	B-PP	O
,	,	,	O	O
standing	stand	VBG	B-VP	O
insulin	insulin	NN	B-NP	O
aspart	aspart	NN	I-NP	O
order	order	NN	I-NP	O
.	.	.	O	O

If	If	IN	B-SBAR	O
ordered	order	VBN	B-NP	O
HS	HS	NN	I-NP	O
administer	administer	NN	I-NP	O
alone	alone	RB	B-ADVP	O
INSULIN	INSULIN	NNP	B-NP	O
ASPART	ASPART	NNP	I-NP	O
7	7	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
AC	AC	NNP	I-NP	O
HOLD	HOLD	NNP	I-NP	O
IF	IF	NNP	I-NP	O
:	:	:	O	O
NPO	NPO	NNP	B-NP	O
LANTUS	LANTUS	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
GLARGINE	GLARGINE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
12	12	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
give	give	VB	B-VP	O
1/2	1/2	CD	B-NP	O
dose	dose	NN	I-NP	O
if	if	IN	B-SBAR	O
NPO	NPO	NN	B-NP	B-protein
IMDUR	IMDUR	NN	I-NP	I-protein
ER	ER	NN	I-NP	I-protein
-LRB-	-LRB-	HYPH	B-NP	O
ISOSORBIDE	ISOSORBIDE	NN	I-NP	O
MONONITRATE	MONONITRATE	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
SR	SR	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
30	30	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
BID	BID	NN	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
SBP	SBP	NN	B-NP	B-protein
<	<	SYM	O	O
100	100	CD	B-NP	O
Instructions	Instruction	NNS	I-NP	O
:	:	:	O	O
do	do	VB	B-VP	O
not	not	RB	I-VP	O
crush	crush	VB	I-VP	O
Imdur	Imdur	NNP	B-NP	O
.	.	.	O	O

thanks	thank	NNS	B-NP	O
.	.	.	O	O

Food/Drug	Food/Drug	NNP	B-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Give	Give	NNP	I-NP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
empty	empty	JJ	I-NP	O
stomach	stomach	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
give	give	VBP	B-VP	O
1hr	1hr	NN	B-NP	O
before	before	IN	B-SBAR	O
or	or	CC	O	O
2hr	2hr	NN	B-NP	O
after	after	IN	B-SBAR	O
food	food	NN	B-NP	B-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
LEVAQUIN	LEVAQUIN	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
LEVOFLOXACIN	LEVOFLOXACIN	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
500	500	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
Q48H	Q48H	NNP	I-NP	I-protein
Food/Drug	Food/Drug	NNP	I-NP	I-protein
Interaction	Interaction	NNP	I-NP	I-protein
Instruction	Instruction	NNP	I-NP	I-protein
Administer	Administer	NNP	I-NP	I-protein
iron	iron	NN	I-NP	I-protein
products	product	NNS	I-NP	I-protein
a	a	DT	B-NP	O
minimum	minimum	NN	I-NP	O
of	of	IN	B-PP	O
2	2	CD	B-NP	O
hours	hour	NNS	I-NP	O
before	before	IN	B-PP	O
or	or	CC	I-PP	O
after	after	IN	I-PP	O
a	a	DT	B-NP	O
levofloxacin	levofloxacin	NN	I-NP	O
or	or	CC	I-NP	O
ciprofloxacin	ciprofloxacin	NN	I-NP	O
dose	dose	NN	I-NP	O
dose	dose	NN	I-NP	O
If	If	IN	B-SBAR	O
on	on	IN	B-PP	O
tube	tube	NN	B-NP	O
feeds	feed	NNS	I-NP	O
,	,	,	O	O
please	please	VB	B-VP	O
cycle	cycle	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
hold	hold	VBP	B-VP	O
1	1	CD	B-NP	O
hr	hr	NN	I-NP	O
before	before	IN	B-PP	O
to	to	TO	B-PP	O
2	2	CD	B-NP	O
hr	hr	NN	I-NP	O
after	after	IN	B-PP	O
-RRB-	-RRB-	NN	B-NP	B-protein
Take	Take	NN	I-NP	I-protein
2	2	CD	B-NP	I-protein
hours	hour	NNS	I-NP	I-protein
before	before	IN	B-PP	O
or	or	CC	B-NP	O
2	2	CD	I-NP	O
hours	hour	NNS	I-NP	O
after	after	IN	B-PP	O
dairy	dairy	NN	B-NP	O
products	product	NNS	I-NP	O
.	.	.	O	O

Override	Override	NNP	B-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
8/19/07	8/19/07	CD	B-NP	O
by	by	IN	B-PP	O
LEIB	LEIB	NNP	B-NP	B-protein
,	,	,	O	O
CHADWICK	CHADWICK	NNP	B-NP	O
S.	S.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
3	3	CD	I-NP	O
MG	MG	NN	I-NP	O
QPM	QPM	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
147826035	147826035	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOFLOXACIN	LEVOFLOXACIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOFLOXACIN	LEVOFLOXACIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
Previous	Previous	JJ	B-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
4/5/07	4/5/07	CD	B-NP	O
by	by	IN	B-PP	O
DEBERRY	DEBERRY	NNP	B-NP	O
,	,	,	O	O
DEWEY	DEWEY	NNP	B-NP	O
O.	O.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
265992736	265992736	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOFLOXACIN	LEVOFLOXACIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOFLOXACIN	LEVOFLOXACIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-ADJP	O
,	,	,	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
Previous	Previous	JJ	B-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
8/10/07	8/10/07	CD	B-NP	O
by	by	IN	B-PP	O
COLLICK	COLLICK	NNP	B-NP	O
,	,	,	O	O
LARRY	LARRY	NNP	B-NP	O
D.	D.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
PROCHLORPERAZINE	PROCHLORPERAZINE	NNP	B-NP	O
&	&	CC	I-NP	O
LEVOFLOXACIN	LEVOFLOXACIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
md	md	NN	B-NP	O
aware	aware	JJ	I-NP	O
Previous	Previous	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
Override	Override	NNP	I-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
11/19/07	11/19/07	CD	B-NP	O
by	by	IN	B-PP	O
CHIRAFISI	CHIRAFISI	NNP	B-NP	O
,	,	,	O	O
JAMAL	JAMAL	NNP	B-NP	O
C.	C.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COMPAZINE	COMPAZINE	NN	B-NP	O
IV	IV	CD	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
728484476	728484476	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOFLOXACIN	LEVOFLOXACIN	NNP	B-NP	O
&	&	CC	I-NP	O
PROCHLORPERAZINE	PROCHLORPERAZINE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
md	md	NN	B-NP	O
aware	aware	JJ	I-NP	O
FLAGYL	FLAGYL	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
METRONIDAZOLE	METRONIDAZOLE	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
500	500	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
Q8H	Q8H	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
with	with	IN	B-PP	O
food	food	NN	B-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
8/19/07	8/19/07	CD	B-NP	O
by	by	IN	B-PP	O
BRIOLA	BRIOLA	NN	B-NP	O
,	,	,	O	O
RODGER	RODGER	NN	B-NP	O
A.	A.	NN	I-NP	O
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
3	3	CD	I-NP	O
MG	MG	NN	I-NP	O
QPM	QPM	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
147826035	147826035	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
METRONIDAZOLE	METRONIDAZOLE	NNP	B-NP	O
,	,	,	I-NP	O
ORAL/VAG	ORAL/VAG	NNP	I-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
Previous	Previous	JJ	B-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
4/5/07	4/5/07	CD	B-NP	O
by	by	IN	B-PP	O
ELLINGHAM	ELLINGHAM	NNP	B-NP	O
,	,	,	O	O
ELVIS	ELVIS	NNP	B-NP	O
L.	L.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
265992736	265992736	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
METRONIDAZOLE	METRONIDAZOLE	NNP	B-NP	O
,	,	,	I-NP	O
ORAL/VAG	ORAL/VAG	NNP	I-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-ADJP	O
,	,	,	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
SEVELAMER	SEVELAMER	NNP	B-NP	O
400	400	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
before	before	IN	B-PP	O
dinner	dinner	NN	B-NP	O
.	.	.	O	O

DIOVAN	DIOVAN	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
VALSARTAN	VALSARTAN	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
120	120	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
COUMADIN	COUMADIN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
3	3	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
ROUTINE	ROUTINE	NNP	I-NP	O
,	,	,	O	O
20	20	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Standard	Standard	NNP	I-NP	O
Admin	Admin	NNP	I-NP	O
Time	Time	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
No	No	NNP	I-NP	O
high	high	JJ	I-NP	O
Vitamin-K	Vitamin-K	NN	I-NP	O
containing	contain	VBG	B-VP	O
foods	food	NNS	B-NP	O
Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	B-ADJP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
8/19/07	8/19/07	CD	B-NP	O
by	by	IN	B-PP	O
SIFERS	SIFERS	NNP	B-NP	O
,	,	,	O	O
YOUNG	YOUNG	NNP	B-NP	O
E.	E.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
METRONIDAZOLE	METRONIDAZOLE	NNP	B-NP	O
,	,	,	I-NP	O
ORAL/VAG	ORAL/VAG	NNP	I-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOFLOXACIN	LEVOFLOXACIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOFLOXACIN	LEVOFLOXACIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
Previous	Previous	NNP	B-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
Override	Override	NNP	I-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
4/5/07	4/5/07	CD	B-NP	O
by	by	IN	B-PP	O
BROYHILL	BROYHILL	NNP	B-NP	O
,	,	,	O	O
HUGH	HUGH	NNP	B-NP	O
M.	M.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
METRONIDAZOLE	METRONIDAZOLE	NNP	B-NP	O
,	,	,	I-NP	O
ORAL/VAG	ORAL/VAG	NNP	I-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOFLOXACIN	LEVOFLOXACIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOFLOXACIN	LEVOFLOXACIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-ADJP	O
,	,	,	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
DIET	DIET	NN	B-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
should	should	MD	B-VP	O
measure	measure	VB	I-VP	O
weight	weight	NN	B-NP	O
daily	daily	JJ	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
Fluid	Fluid	NN	B-NP	O
restriction	restriction	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
gram	gram	NN	I-NP	O
Sodium	Sodium	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Walking	Walk	VBG	B-VP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Hansson	Hansson	NNP	I-NP	O
,	,	,	O	O
Tosdrew	Tosdrew	NNP	B-NP	O
Community	Community	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
,	,	,	O	O
683-430-0751	683-430-0751	CD	B-NP	O
7/10/07	7/10/07	CD	I-NP	O
at	at	IN	B-PP	O
2pm	2pm	NN	B-NP	O
,	,	,	O	O
Arrange	Arrange	NNP	B-NP	O
INR	INR	NNP	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
on	on	IN	B-PP	O
10/3/07	10/3/07	CD	B-NP	O
with	with	IN	B-PP	O
f/u	f/u	NN	B-NP	O
INR	INR	NNP	B-NP	O
's	's	POS	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
every	every	DT	B-NP	O
3	3	CD	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

INR	INR	NN	B-NP	O
's	's	POS	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
JBHMC	JBHMC	NNP	B-NP	B-cell_type
Coumadin	Coumadin	NNP	I-NP	O
Clinic	Clinic	NNP	I-NP	O
ALLERGY	ALLERGY	NNP	I-NP	O
:	:	:	O	O
Codeine	Codeine	NN	B-NP	O
,	,	,	O	O
DIPHENHYDRAMINE	DIPHENHYDRAMINE	NN	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
Abdominal	Abdominal	JJ	B-NP	O
pain	pain	NN	I-NP	O
PRINCIPAL	PRINCIPAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Partial	Partial	NNP	I-NP	O
small	small	JJ	I-NP	O
bowel	bowel	NN	I-NP	O
obstruction	obstruction	NN	I-NP	O
,	,	,	O	O
pneumonia	pneumonia	NN	B-NP	O
,	,	,	O	O
CHF	CHF	NNP	B-NP	O
OTHER	OTHER	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
Diabetes	Diabetes	NNP	I-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
S/p	S/p	NN	B-NP	O
mitral	mitral	JJ	I-NP	O
valve	valve	NN	I-NP	O
replacement	replacement	NN	I-NP	O
,	,	,	O	O
Atrial	Atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
,	,	,	O	O
CHF	CHF	NN	B-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
None	None	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
None	None	NNP	I-NP	O
BRIEF	BRIEF	NNP	I-NP	O
RESUME	RESUME	NNP	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
See	See	VB	B-VP	O
dictation	dictation	NN	B-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
ADDENDUM	ADDENDUM	NN	I-NP	O
1	1	CD	I-NP	O
:	:	:	O	O
CC	CC	NN	B-NP	O
:	:	:	O	O
Abdominal	Abdominal	JJ	B-NP	O
pain	pain	NN	I-NP	O
HPI	HPI	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
86	86	CD	I-NP	O
year-old	year-old	JJ	I-NP	O
woman	woman	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
CHF	CHF	NN	B-NP	B-protein
,	,	,	O	O
chronic	chronic	JJ	B-NP	O
kidney	kidney	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
,	,	,	O	O
Afib	Afib	NN	B-NP	O
on	on	IN	B-PP	O
cuomadin	cuomadin	NN	B-NP	O
,	,	,	O	O
rheumatic	rheumatic	JJ	B-NP	B-protein
heart	heart	NN	I-NP	I-protein
disease	disease	NN	I-NP	I-protein
s/p	s/p	NN	I-NP	I-protein
MVR/TVR	MVR/TVR	NN	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
partial	partial	JJ	B-NP	O
SBO	SBO	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
recent	recent	JJ	I-NP	O
admission	admission	NN	I-NP	O
in	in	IN	B-PP	O
11/29	11/29	CD	B-NP	O
for	for	IN	B-PP	O
abdominal	abdominal	JJ	B-NP	O
pain	pain	NN	I-NP	O
and	and	CC	O	O
bilateral	bilateral	JJ	B-NP	O
aspiration	aspiration	NN	I-NP	O
pneumonia	pneumonia	NN	I-NP	O
who	who	WP	B-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
abdominal	abdominal	JJ	B-NP	O
pain	pain	NN	I-NP	O
for	for	IN	B-PP	O
36	36	CD	B-NP	O
hours	hour	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
pain	pain	NN	I-NP	O
was	be	VBD	B-VP	O
10/10	10/10	CD	B-NP	O
,	,	,	O	O
difficult	difficult	JJ	B-ADJP	O
to	to	TO	B-VP	O
localize	localize	VB	I-VP	O
,	,	,	O	O
and	and	CC	O	O
constant	constant	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
nausea	nausea	NN	B-NP	O
and	and	CC	O	O
3	3	CD	B-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
emesis	emesis	NN	B-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
non-bilious	non-bilious	JJ	I-NP	O
,	,	,	I-NP	O
non-bloody	non-bloody	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
last	last	JJ	I-NP	O
bowel	bowel	NN	I-NP	O
movement	movement	NN	I-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
6/9	6/9	CD	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
recent	recent	JJ	I-NP	O
melena	melena	NN	I-NP	O
or	or	CC	I-NP	O
BRBPR	BRBPR	NN	I-NP	B-protein
,	,	,	O	O
no	no	DT	B-NP	O
diarrhea	diarrhea	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
does	do	VBZ	B-VP	O
report	report	NN	B-NP	O
flatus	flatus	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
reports	report	VBZ	B-VP	O
increasing	increase	VBG	B-NP	O
SOB	SOB	NN	I-NP	B-protein
over	over	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
48	48	CD	I-NP	O
hrs	hr	NNS	I-NP	O
,	,	,	O	O
unclear	unclear	JJ	B-ADJP	O
if	if	IN	B-SBAR	O
orthopnea	orthopnea	NN	B-NP	O
,	,	,	O	O
PND	PND	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
increased	increase	VBN	B-NP	O
leg	leg	NN	I-NP	O
swelling	swelling	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
denies	deny	VBZ	B-VP	O
chest	ch	JJS	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
palpitations	palpitation	NNS	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
fevers	fever	NNS	I-NP	O
or	or	CC	I-NP	O
chills	chill	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
ED	ED	NN	B-NP	O
,	,	,	O	O
temp	temp	NN	B-NP	B-protein
96.5	96.5	CD	I-NP	I-protein
,	,	,	O	O
HR	HR	NN	B-NP	B-protein
76	76	CD	I-NP	I-protein
,	,	,	O	O
BP	BP	NN	B-NP	B-DNA
135/51	135/51	CD	I-NP	I-DNA
,	,	,	O	O
O2sat	O2sat	NN	B-NP	O
97	97	CD	I-NP	O
%	%	NN	I-NP	O
RA	RA	NN	I-NP	O
.	.	.	O	O

CXR	CXR	NN	B-NP	B-protein
showed	show	VBD	B-VP	O
RLL	RLL	NN	B-NP	O
PNA	PNA	NN	I-NP	O
and	and	CC	O	O
pulmonary	pulmonary	JJ	B-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

KUB	KUB	NN	B-NP	B-protein
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
show	show	VB	I-VP	O
free	free	JJ	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

Abd	Abd	NN	B-NP	O
CT	CT	NN	I-NP	O
showed	show	VBD	B-VP	O
partial	partial	JJ	B-NP	O
or	or	CC	I-NP	O
early	early	JJ	I-NP	O
SBO	SBO	NN	I-NP	O
without	without	IN	B-PP	O
transition	transition	NN	B-NP	O
point	point	NN	I-NP	O
.	.	.	O	O

Given	Give	VBN	B-NP	O
1500cc	1500cc	NN	I-NP	O
IVF	IVF	NN	I-NP	O
,	,	,	O	O
2mg	2mg	NN	B-NP	O
Morphine	Morphine	NN	I-NP	O
IV	IV	CD	I-NP	O
,	,	,	O	O
phenergan	phenergan	NN	B-NP	O
25mg	25mg	NN	I-NP	O
iv	iv	NN	I-NP	O
,	,	,	O	O
zofran	zofran	NN	B-NP	O
1mg	1mg	NN	I-NP	O
,	,	,	O	O
cefuroxime	cefuroxime	NN	B-NP	O
750m	750m	NN	I-NP	O
*****	*****	SYM	B-NP	O
PMHx	PMHx	NN	I-NP	O
:	:	:	O	O
Hypertension	Hypertension	NN	B-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
,	,	,	O	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
on	on	IN	B-PP	O
coumadin	coumadin	NN	B-NP	O
,	,	,	O	O
rheumatic	rheumatic	JJ	B-NP	O
heart	heart	NN	I-NP	O
disease	disease	NN	I-NP	O
s/p	s/p	NN	I-NP	O
bioprosthetic	bioprosthetic	JJ	I-NP	O
MVR/TVR	MVR/TVR	NN	I-NP	O
in	in	IN	B-PP	O
2000	2000	CD	B-NP	O
,	,	,	O	O
diastolic	diastolic	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
TTE	TTE	NN	B-NP	B-protein
8/27	8/27	CD	I-NP	I-protein
-LRB-	-LRB-	:	O	O
EF	EF	NN	B-NP	O
45-50	45-50	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
mod	mod	NN	B-NP	O
LVH	LVH	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
RWMA	RWMA	NN	I-NP	B-protein
,	,	,	O	O
s/p	s/p	NN	B-NP	B-protein
MVR	MVR	NN	I-NP	I-protein
,	,	,	O	O
severe	severe	JJ	B-NP	O
TR	TR	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
chronic	chronic	JJ	B-NP	O
kindey	kindey	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
small-bowel	small-bowel	JJ	B-NP	O
obstruction	obstruction	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
hernia	hernia	NN	I-NP	O
repair	repair	NN	I-NP	O
in	in	IN	B-PP	O
2005	2005	CD	B-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
GI	GI	NN	B-NP	B-protein
bleed	bleed	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
angiectasis/lymphangiectasis	angiectasis/lymphangiectasis	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
unclear	unclear	JJ	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
mesenteric	mesenteric	JJ	B-NP	O
ischemia	ischemia	NN	I-NP	O
,	,	,	O	O
s/p	s/p	NN	B-NP	O
right	right	JJ	I-NP	O
total	total	JJ	I-NP	O
hip	hip	NN	I-NP	O
replacement	replacement	NN	I-NP	O
,	,	,	O	O
s/p	s/p	NN	B-NP	O
CVA	CVA	NN	I-NP	O
at	at	IN	B-PP	O
age	age	NN	B-NP	O
55	55	CD	I-NP	O
,	,	,	O	O
Cdiff	Cdiff	NN	B-NP	O
colitis	colitis	NN	I-NP	O
,	,	,	O	O
s/p	s/p	NN	B-NP	O
appendectomy	appendectomy	NN	I-NP	O
*****	*****	SYM	B-VP	O
Medications	Medication	NNS	B-NP	O
on	on	IN	B-PP	O
Admission	Admission	NN	B-NP	O
:	:	:	O	O
Calcium	Calcium	NN	B-NP	O
500mg	500mg	CD	I-NP	O
bid	bid	NN	I-NP	O
,	,	,	O	O
Renagel	Renagel	NNP	B-NP	O
400mg	400mg	CD	I-NP	O
before	before	IN	B-PP	O
dinner	dinner	NN	B-NP	O
only	only	RB	B-ADVP	O
,	,	,	O	O
Coumadin	Coumadin	NN	B-NP	O
3mg	3mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Norvasc	Norvasc	NN	B-NP	O
5mg	5mg	NN	I-NP	O
qam	qam	NN	I-NP	O
&	&	CC	I-NP	O
2.5	2.5	CD	I-NP	O
mg	mg	NN	I-NP	O
qpm	qpm	NN	I-NP	O
,	,	,	O	O
Imdur	Imdur	NNP	B-NP	O
30mg	30mg	CD	I-NP	O
bid	bid	NN	I-NP	O
,	,	,	O	O
Diovan	Diovan	NNP	B-NP	O
120mg	120mg	CD	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
80mg	80mg	CD	I-NP	O
po	po	NN	I-NP	O
bid	bid	NN	I-NP	O
,	,	,	O	O
Novolog	Novolog	NNP	B-NP	O
5u	5u	CD	I-NP	O
qAC	qAC	NN	I-NP	O
+	+	SYM	B-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
,	,	,	O	O
Lantus	Lantus	NNP	B-NP	O
10u	10u	CD	I-NP	O
qhs	qh	NNS	I-NP	O
,	,	,	O	O
Iron	Iron	NNP	B-NP	O
325mg	325mg	CD	I-NP	O
bid	bid	NN	I-NP	O
,	,	,	O	O
Procrit	Procrit	NNP	B-NP	O
5000u	5000u	CD	I-NP	O
qTUES	qTUES	NNP	I-NP	O
,	,	,	O	O
MVI	MVI	NNP	B-NP	O
.	.	.	O	O

*****	*****	SYM	O	O
Alergies	Alergy	NNPS	B-NP	O
:	:	:	O	O
codeine	codeine	NN	B-NP	O
,	,	,	O	O
benadryl	benadryl	NN	B-NP	O
*****	*****	SYM	O	O
Social	Social	NNP	B-NP	O
Hx	Hx	NNP	I-NP	O
:	:	:	O	O
lives	life	NNS	B-NP	O
with	with	IN	B-PP	O
daughter	daughter	NN	B-NP	O
in	in	IN	B-PP	O
Des	Des	NNP	B-NP	O
Squitelocuse	Squitelocuse	NNP	I-NP	O
New	New	NNP	I-NP	O
No	No	NNP	I-NP	O
tobacco	tobacco	NN	I-NP	O
.	.	.	O	O

Rare	Rare	NN	B-NP	O
EtOH	EtOH	NN	I-NP	O
.	.	.	O	O

****	****	SYM	O	O
Physical	Physical	JJ	B-NP	O
Exam	Exam	NN	I-NP	O
on	on	IN	B-PP	O
Admission	Admission	NN	B-NP	O
:	:	:	O	O
T	T	NN	B-NP	B-DNA
100.6	100.6	CD	I-NP	I-DNA
,	,	,	O	O
HR	HR	NN	B-NP	B-protein
82	82	CD	I-NP	I-protein
,	,	,	O	O
BP	BP	NN	B-NP	B-DNA
120/60	120/60	CD	I-NP	I-DNA
,	,	,	O	O
RR16	RR16	NN	B-NP	B-protein
,	,	,	O	O
O2sat	O2sat	NN	B-NP	O
93	93	CD	I-NP	O
%	%	NN	I-NP	O
2L	2L	NN	I-NP	O
FS	FS	NN	I-NP	O
222	222	CD	I-NP	O
.	.	.	O	O

Somnolent	Somnolent	JJ	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
after	after	IN	B-PP	O
2mg	2mg	NN	B-NP	O
morphine	morphine	NN	I-NP	O
iv	iv	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
NAD	NAD	NN	B-NP	O
.	.	.	O	O

OP	OP	NN	B-NP	O
clear	clear	JJ	I-NP	O
,	,	,	I-NP	O
dry	dry	JJ	I-NP	O
MMM	MMM	NN	I-NP	O
.	.	.	O	O

JVP	JVP	NN	B-NP	O
difficult	difficult	JJ	B-ADJP	O
to	to	TO	B-VP	O
assess	assess	VB	I-VP	O
with	with	IN	B-PP	O
severe	severe	JJ	B-NP	O
TR	TR	NN	I-NP	O
and	and	CC	I-NP	O
pulsations	pulsation	NNS	I-NP	O
to	to	TO	B-VP	O
jaw	jaw	VB	I-VP	O
.	.	.	O	O

Heart	Heart	NN	B-NP	O
rhythm	rhythm	NN	I-NP	O
irregular	irregular	JJ	B-ADJP	O
,	,	,	O	O
3/6	3/6	CD	B-NP	O
SEM	SEM	NNP	I-NP	O
loudest	loud	JJS	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
apex	apex	NN	I-NP	O
.	.	.	O	O

Lungs	Lung	NNS	B-NP	O
with	with	IN	B-PP	O
crackles	crackle	NNS	B-NP	B-protein
1/2	1/2	CD	B-NP	I-protein
up	up	IN	B-PP	O
bilat	bilat	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
wheezes	wheeze	NNS	I-NP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
soft	soft	JJ	B-ADJP	O
,	,	,	O	O
nontender	nontender	JJ	B-ADJP	O
even	even	RB	I-ADJP	O
to	to	TO	B-VP	O
deep	deep	VB	I-VP	O
palpation	palpation	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
rebound	rebound	NN	I-NP	O
,	,	,	O	O
normal	normal	JJ	B-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
,	,	,	O	O
passing	pass	VBG	B-VP	O
gas	gas	NN	B-NP	B-DNA
.	.	.	O	O

Guiaic	Guiaic	JJ	B-NP	O
negative	negative	JJ	I-NP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
warm	warm	NN	I-NP	O
,	,	,	O	O
trace	trace	NN	B-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
venous	venous	JJ	B-NP	O
stasis	stasis	NN	I-NP	O
changes	change	NNS	I-NP	O
with	with	IN	B-PP	O
purpura/petechiae	purpura/petechiae	NNS	B-NP	O
on	on	IN	B-PP	O
legs	leg	NNS	B-NP	O
.	.	.	O	O

Somnolent	Somnolent	RB	B-ADVP	O
,	,	,	O	O
Ox2	Ox2	NN	B-NP	B-protein
,	,	,	O	O
grossly	grossly	RB	B-NP	O
nonfocal	nonfocal	JJ	I-NP	O
neurological	neurological	JJ	I-NP	O
exam	exam	NN	I-NP	O
.	.	.	O	O

*****	*****	SYM	O	O
Studies	Study	NNS	B-NP	O
on	on	IN	B-PP	O
Admission	Admission	NN	B-NP	O
:	:	:	O	O
-	-	HYPH	B-NP	O
Labs	Lab	NNPS	I-NP	B-protein
:	:	:	O	O
Na	Na	NN	B-NP	B-protein
135	135	CD	I-NP	I-protein
,	,	,	O	O
K	K	NN	B-NP	B-cell_line
4.1	4.1	NN	I-NP	I-cell_line
,	,	,	O	O
CL	CL	NN	B-NP	B-protein
97	97	CD	I-NP	I-protein
,	,	,	O	O
CO2	CO2	NN	B-NP	O
23	23	CD	I-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	B-DNA
96	96	CD	I-NP	I-DNA
,	,	,	O	O
Cr	Cr	NNP	B-NP	O
2.6	2.6	CD	I-NP	O
,	,	,	O	O
glucose	glucose	NN	B-NP	O
186	186	CD	I-NP	O
.	.	.	O	O

ALT	ALT	NN	B-NP	B-protein
8	8	CD	I-NP	I-protein
,	,	,	O	O
AST	AST	NNP	B-NP	O
13	13	CD	I-NP	O
,	,	,	O	O
Alk	Alk	NNP	B-NP	O
67	67	CD	I-NP	O
,	,	,	O	O
Tbili	Tbili	NNP	B-NP	O
0.9	0.9	CD	I-NP	O
,	,	,	O	O
amylase	amylase	NN	B-NP	B-protein
53	53	CD	I-NP	I-protein
,	,	,	O	O
lipase	lipase	NN	B-NP	O
30	30	CD	I-NP	O
.	.	.	O	O

WBC	WBC	NN	B-NP	B-protein
14.7	14.7	CD	I-NP	I-protein
-LRB-	-LRB-	HYPH	I-NP	O
91	91	CD	I-NP	O
%	%	NN	I-NP	O
polys	poly	NNS	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
hct	hct	NN	B-NP	O
31	31	CD	I-NP	O
,	,	,	O	O
plts	plt	NNS	B-NP	O
377	377	CD	B-NP	O
.	.	.	O	O

INR	INR	NN	B-NP	O
2.3	2.3	CD	I-NP	O
.	.	.	O	O

BNP	BNP	NN	B-NP	B-protein
705	705	CD	I-NP	I-protein
.	.	.	O	O

UA	UA	NNP	B-NP	O
WBC	WBC	NNP	I-NP	O
5	5	CD	I-NP	O
,	,	,	O	O
RBC	RBC	NN	B-NP	B-protein
2	2	CD	I-NP	I-protein
,	,	,	I-NP	O
1	1	CD	I-NP	O
+	+	SYM	I-NP	O
luek	luek	NN	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
+	+	SYM	I-NP	O
bact	bact	NN	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
+	+	SYM	I-NP	O
sq	sq	NN	I-NP	O
epi	epi	NN	I-NP	O
.	.	.	O	O

-	-	HYPH	B-NP	O
EKG	EKG	NN	I-NP	B-protein
:	:	:	O	O
Afib	Afib	NN	B-NP	O
,	,	,	O	O
HR	HR	NN	B-NP	B-protein
79	79	CD	I-NP	I-protein
,	,	,	O	O
poor	poor	JJ	B-NP	O
RWP	RWP	NN	I-NP	O
,	,	,	O	O
isolated	isolate	VBN	B-VP	O
Q	Q	NNP	B-NP	O
in	in	IN	B-PP	O
AvL	AvL	NNP	B-NP	O
,	,	,	O	O
QTc	QTc	NNP	B-NP	O
488	488	CD	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
changes	change	NNS	I-NP	O
from	from	IN	B-PP	O
prior	prior	JJ	B-NP	O
-	-	HYPH	I-NP	O
CXR	CXR	NN	I-NP	B-protein
:	:	:	O	O
Pulmonary	Pulmonary	JJ	B-NP	O
edema	edema	NN	I-NP	O
with	with	IN	B-PP	O
possibly	possibly	RB	B-ADVP	O
underlying	underlie	VBG	B-VP	O
right	right	RB	B-NP	O
lower	low	JJR	I-NP	O
lobe	lobe	NN	I-NP	O
pneumonia	pneumonia	NN	I-NP	O
.	.	.	O	O

Unchanged	Unchanged	JJ	B-NP	O
cardiomegaly	cardiomegaly	NN	I-NP	O
.	.	.	O	O

-	-	HYPH	B-NP	O
KUB	KUB	NN	I-NP	B-protein
:	:	:	O	O
No	No	DT	B-NP	O
pneumoperitoneum	pneumoperitoneum	NN	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
small	small	JJ	B-NP	O
bowel	bowel	NN	I-NP	O
obstruction	obstruction	NN	I-NP	O
.	.	.	O	O

-	-	HYPH	B-NP	O
Abd/pelvis	Abd/pelvis	NN	I-NP	O
CT	CT	NN	I-NP	O
abd	abd	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
I	I	NN	I-NP	O
-	-	HYPH	B-NP	O
-RRB-	-RRB-	NN	I-NP	B-protein
:	:	:	O	O
Partial	Partial	JJ	B-NP	O
or	or	CC	I-NP	O
early	early	JJ	I-NP	O
small	small	JJ	I-NP	O
bowel	bowel	NN	I-NP	O
obstruction	obstruction	NN	I-NP	O
,	,	,	O	O
without	without	IN	B-PP	O
definite	definite	JJ	B-NP	O
transition	transition	NN	I-NP	O
point	point	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
bilateral	bilateral	JJ	B-NP	O
lower	low	JJR	I-NP	O
lobe	lobe	NN	I-NP	O
pneumonias	pneumonia	NNS	I-NP	O
.	.	.	O	O

Cholelithiasis	Cholelithiasis	NN	B-NP	O
.	.	.	O	O

Coronary	Coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
and	and	CC	O	O
atherosclerosis	atherosclerosis	NN	B-NP	O
with	with	IN	B-PP	O
cardiomegaly	cardiomegaly	NN	B-NP	O
.	.	.	O	O

*****	*****	SYM	B-NP	O
Procedures	Procedure	NNS	I-NP	O
:	:	:	O	O
none	none	NN	B-NP	O
Consultants	Consultant	NNS	I-NP	O
:	:	:	O	O
none	none	NN	B-NP	O
*****	*****	SYM	B-NP	O
HOSPITAL	HOSPITAL	NN	I-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
86F	86F	NN	I-NP	O
with	with	IN	B-PP	O
hx	hx	NN	B-NP	B-protein
CHF	CHF	NN	I-NP	I-protein
,	,	,	O	O
Afib	Afib	NN	B-NP	O
,	,	,	O	O
CKD	CKD	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
diabetes	diabetes	NN	B-NP	O
who	who	WP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
with	with	IN	B-PP	O
partial	partial	JJ	B-NP	O
SBO	SBO	NN	I-NP	O
,	,	,	O	O
bilateral	bilateral	JJ	B-NP	O
aspiration	aspiration	NN	I-NP	O
pneumonia	pneumonia	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
CHF	CHF	NN	B-NP	O
exacerbation	exacerbation	NN	I-NP	O
.	.	.	O	O

-	-	HYPH	B-NP	O
GI	GI	NN	I-NP	O
:	:	:	O	O
Admitted	Admit	VBN	B-VP	O
with	with	IN	B-PP	O
partial	partial	JJ	B-NP	O
SBO	SBO	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
wtih	wtih	JJ	B-NP	O
conservative	conservative	JJ	I-NP	O
management	management	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
NGT	NGT	NN	I-NP	B-protein
was	be	VBD	B-VP	O
required	require	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
SBO	SBO	NN	I-NP	B-protein
resolved	resolve	VBN	B-VP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
passing	pass	VBG	I-VP	O
stool	stool	NN	B-NP	O
and	and	CC	O	O
tolerating	tolerate	VBG	B-VP	O
a	a	DT	B-NP	O
normal	normal	JJ	I-NP	O
diet	diet	NN	I-NP	O
.	.	.	O	O

-	-	HYPH	B-NP	O
CV	CV	NN	I-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
diastolic	diastolic	JJ	B-NP	O
dysfunction	dysfunction	NN	I-NP	O
.	.	.	O	O

Echo	Echo	NNP	B-NP	O
8/27	8/27	CD	I-NP	O
with	with	IN	B-PP	O
EF	EF	NN	B-NP	O
45-50	45-50	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
RWMA	RWMA	NN	I-NP	B-protein
,	,	,	O	O
mod	mod	NN	B-NP	O
LAE	LAE	NN	I-NP	O
and	and	CC	I-NP	O
RAE	RAE	NN	I-NP	B-protein
,	,	,	O	O
bioprosthetic	bioprosthetic	JJ	B-NP	O
MV	MV	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
tr	tr	NN	I-NP	B-protein
MR	MR	NN	I-NP	I-protein
,	,	,	O	O
tr	tr	NN	B-NP	B-protein
AR	AR	NNS	I-NP	I-protein
,	,	,	O	O
severe	severe	JJ	B-NP	O
TR	TR	NN	I-NP	O
,	,	,	O	O
mild-mod	mild-mod	JJ	B-NP	O
PR	PR	NN	I-NP	B-protein
.	.	.	O	O

She	She	PRP	B-NP	O
reported	report	VBD	B-VP	O
SOB	SOB	NN	B-NP	B-protein
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
which	which	WDT	B-NP	O
ws	w	VBZ	B-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
CHF	CHF	NN	I-NP	O
exacerbation	exacerbation	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
agressively	agressively	RB	I-VP	O
diuresed	diurese	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
partial	partial	JJ	I-NP	O
SBO	SBO	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
variable	variable	JJ	B-NP	O
doses	dose	NNS	I-NP	O
of	of	IN	B-PP	O
lasix	lasix	NN	B-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
80-200mg	80-200mg	JJ	I-NP	B-protein
po	po	NN	I-NP	I-protein
bid	bid	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
at	at	IN	B-PP	O
home	home	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
given	give	VBN	I-VP	O
lasix	lasix	NN	B-NP	O
80mg	80mg	NN	I-NP	O
bid	bid	NN	I-NP	O
which	which	WDT	B-NP	O
required	require	VBD	B-VP	O
additional	additional	JJ	B-NP	O
doses	dose	NNS	I-NP	O
of	of	IN	B-PP	O
lasix	lasix	CD	B-NP	O
iv	iv	JJ	I-NP	O
prn	prn	NN	I-NP	O
to	to	TO	B-VP	O
diurese	diurese	VB	I-VP	O
,	,	,	O	O
so	so	IN	O	O
the	the	DT	B-NP	O
dose	dose	NN	I-NP	O
was	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
to	to	TO	B-PP	O
160mg	160mg	CD	B-NP	O
po	po	NN	I-NP	O
bid	bid	NN	I-NP	O
.	.	.	O	O

Repeat	Repeat	NN	B-NP	O
CXR	CXR	NN	I-NP	O
on	on	IN	B-PP	O
3/17	3/17	CD	B-NP	O
looks	look	VBZ	B-VP	O
a	a	DT	B-NP	O
little	little	RB	I-NP	O
better	good	JJR	B-ADJP	O
than	than	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

Overall	Overall	RB	B-ADVP	O
her	her	PRP$	B-NP	O
SOB	SOB	NN	I-NP	B-protein
and	and	CC	I-NP	O
hypoxia	hypoxia	NN	I-NP	O
improved	improve	VBD	B-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
no	no	RB	B-ADVP	O
longer	longer	RBR	I-ADVP	O
required	require	VBD	B-VP	O
supplemental	supplemental	JJ	B-NP	O
oxygen	oxygen	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
hypertension	hypertension	NN	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
norvasc	norvasc	NN	B-NP	O
and	and	CC	I-NP	O
imdur	imdur	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
Afib	Afib	NN	B-NP	B-protein
,	,	,	O	O
now	now	RB	B-ADVP	O
on	on	IN	B-PP	O
coumadin	coumadin	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
rate	rate	NN	I-NP	O
was	be	VBD	B-VP	O
adequately	adequately	RB	I-VP	O
controlled	control	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
coumadin	coumadin	NN	I-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
held	hold	VBN	I-VP	O
due	due	JJ	B-PP	O
to	to	TO	B-PP	O
possible	possible	JJ	B-NP	O
procedures	procedure	NNS	I-NP	O
related	relate	VBN	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
SBO	SBO	NN	I-NP	B-protein
.	.	.	O	O

The	The	DT	B-NP	O
INR	INR	NN	I-NP	B-protein
remained	remain	VBD	B-VP	O
in	in	IN	B-PP	O
2-3	2-3	CD	B-NP	O
range	range	NN	I-NP	O
,	,	,	O	O
likely	likely	RB	B-ADJP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
antibiotics	antibiotic	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
Coumadin	Coumadin	NN	I-NP	O
was	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
on	on	IN	B-PP	O
10/20	10/20	CD	B-NP	O
as	as	IN	B-PP	O
the	the	DT	B-NP	O
INR	INR	NN	I-NP	B-protein
was	be	VBD	B-VP	O
trending	trend	VBG	I-VP	O
down	down	IN	B-PRT	O
,	,	,	O	O
and	and	CC	O	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
at	at	IN	B-PP	O
lower	low	JJR	B-NP	O
dose	dose	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
2mg	2mg	NN	I-NP	O
instead	instead	RB	B-CONJP	O
of	of	IN	I-CONJP	O
3mg	3mg	NN	B-NP	O
-RRB-	-RRB-	HYPH	B-ADVP	O
given	give	VBN	B-PP	O
the	the	DT	B-NP	O
antibiotics	antibiotic	NNS	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
will	will	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
and	and	CC	O	O
coumadin	coumadin	NN	B-NP	O
adjusted	adjust	VBN	B-VP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
.	.	.	O	O

-	-	HYPH	B-NP	O
Pulmonary	Pulmonary	NNP	I-NP	O
:	:	:	O	O
She	She	NNP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
aspiration	aspiration	NN	B-NP	O
PNA	PNA	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
Abd	Abd	NNP	I-NP	O
CT	CT	NN	I-NP	O
showed	show	VBD	B-VP	O
bilateral	bilateral	JJ	B-NP	O
lower	low	JJR	I-NP	O
lobe	lobe	NN	I-NP	O
PNA	PNA	NN	I-NP	O
,	,	,	O	O
likely	likely	RB	B-NP	O
aspiration	aspiration	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
levo	levo	NN	B-NP	O
and	and	CC	I-NP	O
flagyl	flagyl	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
WBC	WBC	NN	I-NP	B-protein
was	be	VBD	B-VP	O
elevated	elevate	VBN	I-VP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
and	and	CC	O	O
decreased	decrease	VBN	B-VP	O
during	during	IN	B-PP	O
hospitalization	hospitalization	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
afebrile	afebrile	JJ	B-ADJP	O
.	.	.	O	O

With	With	IN	B-PP	O
treatment	treatment	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
pneumonia	pneumonia	NN	I-NP	O
and	and	CC	I-NP	O
CHF	CHF	NN	I-NP	B-protein
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
no	no	RB	B-NP	O
longer	longer	RBR	I-NP	O
hypoxic	hypoxic	JJ	I-NP	O
or	or	CC	I-NP	O
SOB	SOB	NN	I-NP	B-protein
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
continue	continue	VB	I-VP	O
levofloxacin	levofloxacin	NN	B-NP	O
and	and	CC	I-NP	O
flagyl	flagyl	NN	I-NP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
8-day	8-day	JJ	I-NP	O
course	course	NN	I-NP	O
.	.	.	O	O

-	-	HYPH	O	O
Renal	Renal	JJ	B-ADJP	O
:	:	:	O	O
She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
CKD	CKD	NN	B-NP	B-protein
with	with	IN	B-PP	O
Cr	Cr	NN	B-NP	O
baseline	baseline	NN	I-NP	O
of	of	IN	B-PP	O
2.6-2	2.6-2	CD	B-NP	O
.8	.8	CD	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
Cr	Cr	NN	I-NP	O
was	be	VBD	B-VP	O
2.6	2.6	CD	B-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
and	and	CC	O	O
2.3	2.3	CD	B-NP	O
on	on	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
continued	continue	VBD	B-VP	O
home	home	NN	B-NP	O
sevelamer	sevelamer	NN	I-NP	O
.	.	.	O	O

-	-	HYPH	B-NP	O
Diabetes	Diabete	NNPS	I-NP	O
:	:	:	O	O
Her	Her	PRP$	B-NP	O
insulin	insulin	NN	I-NP	B-protein
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
held	hold	VBN	I-VP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
NPO	NPO	NN	B-NP	B-protein
for	for	IN	B-PP	O
the	the	DT	B-NP	O
SBO	SBO	NN	I-NP	B-protein
.	.	.	O	O

When	When	WRB	B-ADVP	O
her	her	PRP$	B-NP	O
SBO	SBO	NN	I-NP	B-protein
resolved	resolve	VBN	B-VP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
eating	eat	VBG	I-VP	O
again	again	RB	B-ADVP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
regimen	regimen	NN	I-NP	O
of	of	IN	B-PP	O
lantus	lantus	NN	B-NP	B-protein
100	100	CD	B-NP	I-protein
units	unit	NNS	I-NP	I-protein
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Novolog	Novolog	NNP	B-NP	O
5	5	CD	I-NP	O
units	unit	NNS	I-NP	O
qac	qac	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Novolog	Novolog	NNP	B-NP	O
sliding	slide	VBG	I-NP	O
scale	scale	NN	I-NP	O
was	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
fingersticks	fingerstick	NNS	I-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
high	high	JJ	B-ADJP	O
,	,	,	O	O
perhaps	perhaps	RB	B-ADVP	O
due	due	IN	B-PP	O
to	to	TO	I-PP	O
pneumonia	pneumonia	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
insulin	insulin	NN	I-NP	B-protein
was	be	VBD	B-VP	O
titrated	titrate	VBN	I-VP	O
up	up	RP	B-PRT	O
for	for	IN	B-PP	O
better	good	JJR	B-NP	O
glucose	glucose	NN	I-NP	O
control	control	NN	I-NP	O
to	to	TO	B-PP	O
Lantus	Lantus	NNP	B-NP	O
12	12	CD	I-NP	O
units	unit	NNS	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Novolog	Novolog	NNP	B-NP	O
7	7	CD	I-NP	O
units	unit	NNS	I-NP	O
qac	qac	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Novolog	Novolog	NNP	B-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
daughter	daughter	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
nurse	nurse	NN	I-NP	O
and	and	CC	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
and	and	CC	I-VP	O
adjust	adjust	VB	I-VP	O
her	her	PRP$	B-NP	O
insulin	insulin	NN	I-NP	B-protein
at	at	IN	B-PP	O
home	home	NN	B-NP	O
.	.	.	O	O

HbA1c	HbA1c	NN	B-NP	O
8.2	8.2	CD	I-NP	O
.	.	.	O	O

-	-	HYPH	B-NP	O
ID	ID	NN	I-NP	O
:	:	:	O	O
Treatment	Treatment	NN	B-NP	O
for	for	IN	B-PP	O
aspiration	aspiration	NN	B-NP	O
pneumonia	pneumonia	NN	I-NP	O
as	as	IN	B-PP	O
above	above	IN	B-PP	O
with	with	IN	B-PP	O
levofloxacin	levofloxacin	NN	B-NP	O
and	and	CC	I-NP	O
flagyl	flagyl	NN	I-NP	O
.	.	.	O	O

Ucx	Ucx	NN	B-NP	B-protein
with	with	IN	B-PP	O
mixed	mix	VBN	B-NP	O
flora	flora	NN	I-NP	O
.	.	.	O	O

-	-	HYPH	B-NP	O
Heme	Heme	NN	I-NP	B-protein
:	:	:	O	O
Hct	Hct	NN	B-NP	O
at	at	IN	B-PP	O
baseline	baseline	NN	B-NP	O
.	.	.	O	O

As	As	IN	B-PP	O
above	above	IN	B-PP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
remained	remain	VBD	B-VP	O
high	high	JJ	B-ADJP	O
off	off	IN	B-PP	O
coumadin	coumadin	NN	B-NP	O
,	,	,	O	O
likely	likely	RB	B-ADJP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
antibiotics	antibiotic	NNS	I-NP	O
.	.	.	O	O

Coumadin	Coumadin	NN	B-NP	O
restarted	restart	VBD	B-VP	O
on	on	IN	B-PP	O
10/20	10/20	CD	B-NP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
lower	low	JJR	I-NP	O
dose	dose	NN	I-NP	O
.	.	.	O	O

INR	INR	NN	B-NP	B-protein
will	will	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
and	and	CC	O	O
coumadin	coumadin	NN	B-NP	O
adjusted	adjust	VBN	B-VP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
-	-	HYPH	O	O
Nutrition	Nutrition	NN	B-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
radiologic	radiologic	JJ	I-NP	O
swallowing	swallow	VBG	I-NP	O
evaluation	evaluation	NN	I-NP	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
deep	deep	JJ	B-NP	O
laryngeal	laryngeal	JJ	I-NP	O
penetration	penetration	NN	I-NP	O
with	with	IN	B-PP	O
thin	thin	JJ	B-NP	O
and	and	CC	I-NP	O
nectar-thick	nectar-thick	JJ	I-NP	O
liquid	liquid	NN	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
aspiration	aspiration	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
tiny	tiny	JJ	I-NP	O
Zenker	Zenker	NNP	I-NP	O
diverticulum	diverticulum	NN	I-NP	O
.	.	.	O	O

Diet	Diet	JJ	B-NP	O
recommendations	recommendation	NNS	I-NP	O
were	be	VBD	B-VP	O
ground	ground	NN	B-NP	O
diet	diet	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
for	for	IN	B-PP	O
lack	lack	NN	B-NP	O
of	of	IN	B-PP	O
teech	teech	NN	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
and	and	CC	O	O
thin	thin	JJ	B-NP	O
liquids	liquid	NNS	I-NP	O
.	.	.	O	O

-	-	HYPH	B-NP	O
Disposition	Disposition	NN	I-NP	O
:	:	:	O	O
PT	PT	NN	B-NP	O
recommended	recommend	VBD	B-VP	O
rehab	rehab	NN	B-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
and	and	CC	I-NP	O
daughter	daughter	NN	I-NP	O
prefer	prefer	VBP	B-VP	O
patient	patient	NN	B-NP	O
to	to	TO	B-VP	O
go	go	VB	I-VP	O
home	home	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
services	service	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
daughter	daughter	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
nurse	nurse	NN	I-NP	O
.	.	.	O	O

New	New	JJ	B-NP	O
PCP	PCP	NN	I-NP	O
is	be	VBZ	B-VP	O
Dr.	Dr.	NNP	B-NP	O
Hermes	Hermes	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
geriatrics	geriatric	NNS	I-NP	O
-RRB-	-RRB-	''	O	O
at	at	IN	B-PP	O
12/10	12/10	CD	B-NP	O
at	at	IN	B-PP	O
2pm	2pm	NN	B-NP	O
at	at	IN	B-PP	O
Mawe	Mawe	NNP	B-NP	O
Tesparks	Tesparks	NNP	I-NP	O
In	In	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
.	.	.	O	O

-	-	HYPH	B-NP	O
Code	Code	NNP	I-NP	O
:	:	:	O	O
Full	Full	NNP	B-NP	O
-	-	:	O	O
Addended	Addended	NNP	B-NP	O
Bjorseth	Bjorseth	NNP	I-NP	O
,	,	,	O	O
Rosario	Rosario	NNP	B-NP	O
D.	D.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
GO640	GO640	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
on	on	IN	B-PP	O
1/15/07	1/15/07	CD	B-NP	O
@	@	NN	I-NP	O
02	02	CD	I-NP	O
:	:	:	O	O
54	54	CD	B-NP	O
PM	PM	NN	I-NP	O
ADDITIONAL	ADDITIONAL	NN	I-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Pneumonia	Pneumonia	NNP	B-NP	O
:	:	:	O	O
She	She	NNP	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
levofloxacin	levofloxacin	NN	B-NP	O
and	and	CC	I-NP	O
flagyl	flagyl	NN	I-NP	O
to	to	TO	B-VP	O
treat	treat	VB	I-VP	O
her	her	PRP$	B-NP	O
pneumonia	pneumonia	NN	I-NP	O
to	to	TO	B-VP	O
complete	complete	VB	I-VP	O
an	an	DT	B-NP	O
8-day	8-day	JJ	I-NP	O
course	course	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
will	will	MD	B-VP	O
end	end	VB	I-VP	O
on	on	IN	B-PP	O
6/20	6/20	CD	B-NP	O
2	2	CD	I-NP	O
.	.	.	O	O

CHF	CHF	NN	B-NP	B-protein
:	:	:	O	O
She	She	PRP	B-NP	O
will	will	MD	B-VP	O
continue	continue	VB	I-VP	O
to	to	TO	I-VP	O
take	take	VB	I-VP	O
the	the	DT	B-NP	O
lasix	lasix	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Hypertension	Hypertension	NN	B-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
should	should	MD	B-VP	O
continue	continue	VB	I-VP	O
to	to	TO	I-VP	O
take	take	VB	I-VP	O
her	her	PRP$	B-NP	O
previous	previous	JJ	I-NP	O
medications	medication	NNS	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Diabetes	Diabete	NNS	B-NP	O
:	:	:	O	O
Her	Her	PRP$	B-NP	O
insulin	insulin	NN	I-NP	B-protein
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
increased	increase	VBN	I-VP	O
during	during	IN	B-PP	O
hospitalization	hospitalization	NN	B-NP	O
.	.	.	O	O

Continue	Continue	NNP	B-NP	O
to	to	TO	B-VP	O
monitor	monitor	VB	I-VP	O
the	the	DT	B-NP	O
glucose	glucose	NN	I-NP	O
levels	level	NNS	I-NP	O
and	and	CC	O	O
adjusting	adjust	VBG	B-VP	O
her	her	PRP$	B-NP	O
insulin	insulin	NN	I-NP	B-protein
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Coumadin	Coumadin	NN	B-NP	O
:	:	:	O	O
Her	Her	PRP$	B-NP	O
coumadin	coumadin	NN	I-NP	O
was	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
on	on	IN	B-PP	O
10/20	10/20	CD	B-NP	O
at	at	IN	B-PP	O
2pm	2pm	NN	B-NP	B-DNA
-LRB-	-LRB-	HYPH	O	I-DNA
lower	low	JJR	B-NP	O
dose	dose	NN	I-NP	O
than	than	IN	B-PP	O
prior	prior	JJ	B-ADJP	O
due	due	JJ	B-PP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
antibiotics	antibiotic	NNS	B-NP	O
increasing	increase	VBG	B-VP	O
the	the	DT	B-NP	O
INR	INR	NN	I-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
low	low	JJ	B-ADJP	O
at	at	IN	B-PP	O
1.5	1.5	CD	B-NP	O
and	and	CC	I-NP	O
1.4	1.4	CD	I-NP	O
,	,	,	O	O
so	so	IN	O	O
the	the	DT	B-NP	O
coumadin	coumadin	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
increased	increase	VBN	I-VP	O
to	to	TO	B-PP	O
3mg	3mg	NN	B-NP	O
at	at	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

Continue	Continue	NNP	B-NP	O
to	to	TO	B-VP	O
monitor	monitor	VB	I-VP	O
her	her	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
and	and	CC	O	O
adjust	adjust	VBP	B-VP	O
her	her	PRP$	B-NP	O
coumadin	coumadin	NN	I-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Continue	Continue	JJ	B-NP	O
home	home	NN	I-NP	O
PT	PT	NN	I-NP	O
as	as	IN	B-SBAR	O
recommended	recommend	VBN	B-VP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Seek	Seek	JJ	B-NP	O
medical	medical	JJ	I-NP	O
attention	attention	NN	I-NP	O
if	if	IN	B-SBAR	O
she	she	PRP	B-NP	O
develops	develop	VBZ	B-VP	O
fever	fever	RB	B-ADVP	O
,	,	,	O	O
chills	chill	NNS	B-NP	O
,	,	,	O	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
worsening	worsen	VBG	B-VP	O
cough	cough	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
any	any	DT	B-NP	O
other	other	JJ	I-NP	O
concerning	concern	VBG	I-NP	O
symptoms	symptom	NNS	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
an	an	DT	B-NP	O
appointment	appointment	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
new	new	JJ	I-NP	O
PCP	PCP	NN	I-NP	B-DNA
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Lamar	Lamar	NNP	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Dept	Dept	NNP	I-NP	O
of	of	IN	B-PP	O
Geriatrics	Geriatrics	NNP	B-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
7/10/07	7/10/07	CD	B-NP	O
at	at	IN	B-PP	O
Orvo	Orvo	NNP	B-NP	O
Glumflu	Glumflu	NNP	I-NP	O
Carn	Carn	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Pneumonia	Pneumonia	NNP	B-NP	O
:	:	:	O	O
Patient	Patient	NNP	B-NP	O
will	will	MD	B-VP	O
complete	complete	VB	I-VP	O
an	an	DT	B-NP	O
8-day	8-day	JJ	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
levo	levo	NN	B-NP	O
and	and	CC	I-NP	O
flagyl	flagyl	NN	I-NP	O
.	.	.	O	O

Monitor	Monitor	NN	B-NP	O
for	for	IN	B-PP	O
resolution	resolution	NN	B-NP	O
of	of	IN	B-PP	O
pneumonia	pneumonia	NN	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

CHF	CHF	NN	B-NP	B-protein
:	:	:	O	O
Patient	Patient	NN	B-NP	O
will	will	MD	B-VP	O
continue	continue	VB	I-VP	O
lasix	lasix	NN	B-NP	O
.	.	.	O	O

Continue	Continue	NNP	B-NP	O
to	to	TO	B-VP	O
monitor	monitor	VB	I-VP	O
volume	volume	NN	B-NP	O
status	status	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Afib	Afib	NN	B-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
will	will	MD	B-VP	O
continue	continue	VB	I-VP	O
coumadin	coumadin	NN	B-NP	O
,	,	,	O	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
monitored	monitor	VBN	I-VP	O
and	and	CC	I-VP	O
adjusted	adjust	VBN	I-VP	O
by	by	IN	B-PP	O
Coumadin	Coumadin	NNP	B-NP	O
Clinic	Clinic	NNP	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Diabetes	Diabete	NNS	B-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
will	will	MD	B-VP	O
continue	continue	VB	I-VP	O
insulin	insulin	NN	B-NP	O
regimen	regimen	NN	I-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

PCP	PCP	NN	B-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
will	will	MD	B-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
new	new	JJ	I-NP	O
PCP	PCP	NN	I-NP	B-DNA
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Rowling	Rowling	NNP	I-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
she	she	PRP	B-NP	O
will	will	MD	B-VP	O
see	see	VB	I-VP	O
on	on	IN	B-PP	O
10/8	10/8	CD	B-NP	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
TOPOLEWSKI	TOPOLEWSKI	NNP	B-NP	O
,	,	,	O	O
JERROLD	JERROLD	NNP	B-NP	O
T.	T.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
GO640	GO640	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
8/19/07	8/19/07	CD	I-NP	O
@	@	,	I-NP	O
01	01	CD	I-NP	O
Addended	Addended	NNP	I-NP	O
Mansbridge	Mansbridge	NNP	I-NP	O
,	,	,	O	O
Gregg	Gregg	NNP	B-NP	O
R.	R.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
GO640	GO640	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
on	on	IN	B-PP	O
1/15/07	1/15/07	CD	B-NP	O
@	@	NN	I-NP	O
02	02	CD	I-NP	O
:	:	:	O	O
54	54	CD	B-NP	O
PM	PM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

